The Correlation Between Gleason Score and BMI in Patients with Prostate Cancer
DOI:
https://doi.org/10.56981/Keywords:
Prostate cancer, PSA, Body mass index, Gleason score.Abstract
Objective: This study aimed to investigate whether body mass index (BMI) is correlates to severity of prostate.
Materials and Methods: Medical records of 50 Iraqi patients who visited the Imam Hussain Center for Oncological and Hematological Diseases Directorate were collected during the period extending between (November 2021 to April 2022), their age was ranged from 51 to 80 years.
Results and Discussion:
In this study has been observed the relationship between BMI and the severity of prostate cancer based on Gleason scores was a weak positive (when BMI increased, Gleason scores also increased) weak significant correlation between BMI and the severity of prostate cancer based on Gleason scores, and these results revealed of the higher the Gleason scores, the higher of the BMI of prostate cancer patients in this study.
Conclusion: Prostate cancer patients' BMI had a weakly positive correlation with their Gleason score.
References
References
1. Ittmann M. Anatomy and Histology of the Human and Murine Prostate. Cold Spring Harb Perspect Med. 2018;8(5).
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136(5):E359-E86.
3. Spahn M, Kneitz S, Scholz CJ, Stenger N, Rüdiger T, Ströbel P, et al. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer. 2010;127(2):394-403.
4. Chen N, Zhou Q. The evolving Gleason grading system. Chinese Journal of Cancer Research. 2016;28(1):58.
5. Montironi R, Mazzuccheli R, Scarpelli M, Lopez‐Beltran A, Fellegara G, Algaba F. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies. BJU international. 2005;95(8):1146-52.
6. Humphrey PA. Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol. 2004;17(3):292-306.
7. Organization WH. World Health Organization obesity and overweight fact sheet. 2016. 2019.
8. Markowitz JS. Body mass index (BMI). Mortality and Its Risk Factors Among Professional Athletes: Springer; 2018. p. 39-49.
9. Zhou F, Chen X, Pu J, Ouyang J, Li G, Ping J, et al. Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population. Oncotarget. 2016;7(39):63338-41.
10. Freedland S, Banez L, Sun L, Fitzsimons N, Moul J. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate cancer and prostatic diseases. 2009;12(3):259-63.
11. Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(S1):S3-s14.
12. Group LAR. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New England journal of medicine. 2013;369(2):145-54.
13. Parikesit D, Mochtar CA, Umbas R, Hamid ARAH. The impact of obesity towards prostate diseases. Prostate Int. 2016;4(1):1-6.
14. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine. 2003;348(17):1625-38.
15. Engeland A, Tretli S, Bjørge T. Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men. British journal of cancer. 2003;89(7):1237-42.
16. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiology Biomarkers & Prevention. 2006;15(10):1977-83.
17. Andersson S-O, Wolk A, Bergström R, Adami H-O, Engholm G, Englund A, et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. Journal of the National Cancer Institute. 1997;89(5):385-9.
18. Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ, et al. Body mass index and risk of prostate cancer in US health professionals. Journal of the National Cancer Institute. 2003;95(16):1240-4.
19. Allott EH, Masko EM, Freedland SJ. Obesity and Prostate Cancer: Weighing the Evidence. European Urology. 2013;63(5):800-9.
20. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiology, Biomarkers & Prevention. 2007;16(1):63-9.
21. Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2007;109(4):675-84.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 https://creativecommons.org/licenses/by/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
